In the American Cancer Society’s study of newly diagnosed breast cancer, 10% of patients had breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2) mutations, whereas 35% of patients with TNBC carried a BRCA1 mutation, and 8% carried a BRCA2 mutation. Here, BRCA1 is linked to breast carcinoma.